## TEM: Tempus AI, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 3.3% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($62.86)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Canaccord Genui | $80 | $95 | -16% |
| 2025-12-15 | JP Morgan | $80 | $85 | -6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Canaccord Genui | main | Buy |
| 2025-12-15 | JP Morgan | main | Neutral |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 34.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- JPMORGAN CHASE & CO: 5.7% (+106.8%)
- BAILLIE GIFFORD & CO: 5.6% (-19.9%)
- Vanguard Group Inc: 5.5% (+22.1%)
- ARK Investment Manag: 4.2% (-3.3%)
- Blackrock Inc.: 3.9% (+62.8%)

### Key Risks

1. High beta (2.74) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Elevated short interest (13.7%): bears positioning against stock.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Momentum building: MRS_20 improving +16.0% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.49 indicates undervaluation relative to growth. Balance sheet: strong liquidity (3.3x). Revenue growth strong at 24% YoY. Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.4B |
| Beta | 1.00 |
| 52W Range | $31.36 - $104.32 |
| Short Interest | 13.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.49 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 strengthening from -12.7% to 3.3% (+16.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.7pp (needs >4.0% for momentum thesis). MRS_5 at 9.2% confirms short-term momentum alignment. AM_20 at 4.1% shows strong absolute momentum above own 20MA. MACD histogram positive (0.53), confirming momentum. RSI neutral at 53. Elevated volume (1.6x 20MA), institutional activity likely. OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.33% (CS: 71) | Neutral |
| RSI_14 | 53.2 | Neutral |
| MACD Histogram | 0.53 | Bullish |
| vs SMA20 | 1.041x | Above |
| vs SMA50 | 0.955x | Below |
| vs SMA200 | 1.022x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $69.54
- **Stop Loss:** $62.86 (9.6% risk)
- **Target:** $76.22 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 197
- **Position Value:** $13,699.38
- **Portfolio %:** 13.70%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-02-24 (Est: $-0.05)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.18 | $-0.11 | +37.3% |
| 2025Q2 | $-0.25 | $-0.22 | +13.0% |
| 2025Q1 | $-0.27 | $-0.24 | +10.2% |
| 2024Q4 | $-0.15 | $-0.18 | -17.5% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_20*